## **Core Concept**
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation. It occurs when immune cells from the transplanted graft (donor cells) recognize the recipient's body as foreign and mount an immune response against it. The disease involves multiple organ systems and is mediated by T lymphocytes.

## **Why the Correct Answer is Right**
The correct answer, , is involved in graft-versus-host disease through the action of T lymphocytes. T cells, particularly CD4+ and CD8+ T cells, play a central role in the pathogenesis of GVHD. They recognize host antigens presented by antigen-presenting cells (APCs) and become activated, leading to the production of cytokines and the activation of effector cells that damage host tissues.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is actually correct in the context of GVHD, as T cells are crucial. However, assuming it refers to a mechanism or cell type involved: T cells are directly involved.
* **Option B:** - This could refer to various immune cells or mechanisms; if it involves immune cells or cytokines that contribute to GVHD, it's incorrect because it does participate.
* **Option D:** - Similar to B, if it refers to aspects of the immune response or specific cells that contribute to GVHD, it's incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **GVHD prophylaxis** often involves immunosuppressive drugs and T-cell depletion strategies. Understanding that T cells are central to GVHD helps in grasping why these strategies are effective. GVHD is a significant cause of morbidity and mortality after allogeneic stem cell transplantation, making its prevention and management critical.

## **Correct Answer:** .